Funding Details
- Awarder
- Inbox
- Date Award
- October 28, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$92,000,000
Company Info
- Traction
- Multiple ADC programs in development with clinical trials expected to begin in 2025.
- Company Description
- Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.
- Market
- Oncology
- Location
-
San Francisco,
California,
USA
- Coinvestors
- BioGeneration Ventures, Brabantse Ontwikkelings Maatschappij, GIMV, HealthCap, M Ventures, Novo Holdings, Red Tree Venture Capital
Links